Press Release
InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355
16 Sep, 2021
138
3545
InnoCare Announces Clearance by U.S. FDA of Clinical Trial of pan-TRK Inhibitor ICP-723
31 Aug, 2021
123
3522
InnoCare Releases 2021 Half Year Results and Business Highlights
29 Aug, 2021
186
3514
Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
17 Aug, 2021
166
3504
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332
16 Aug, 2021
115
3500
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP in China
11 Aug, 2021
93
3498
BIOGEN AND INNOCARE ANNOUNCE LICENSE AND COLLABORATION AGREEMENT FOR ORELABRUTINIB, AN INNOVATIVE CNS PENETRANT BTK INHIBITOR FOR THE POTENTIAL TREATMENT OF MULTIPLE SCLEROSIS
13 Jul, 2021
281
3482
InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL
28 Jun, 2021
197
3475